Bausch Health Cos

Bausch Health Cos's reported carbon emissions

Bausch Health Companies, headquartered in CA and operating in the Pharmaceutical Preparation Manufacturing industry, reported approximately 101.9 million kg CO2e in total emissions for 2023. This figure encompasses Scope 1, Scope 2, and Scope 3 emissions. For the same year, Scope 1 emissions were approximately 49.9 million kg CO2e, and Scope 2 emissions (market-based) stood at approximately 52.0 million kg CO2e. Scope 3 emissions in 2023 were primarily from waste generated in operations, amounting to approximately 27.1 million kg CO2e. In 2022, Bausch Health Companies reported approximately 97.2 million kg CO2e in total emissions. Scope 1 emissions were approximately 46.7 million kg CO2e, and Scope 2 emissions (market-based) were approximately 50.5 million kg CO2e. Waste generated in operations, a component of Scope 3, accounted for approximately 19.3 million kg CO2e. Bausch Health Companies has established near-term science-based targets through the Science Based Targets initiative (SBTi) for BHC Ltd, which commits to reducing Scope 1 and Scope 2 greenhouse gas emissions by 42% by 2030, using a 2020 base year. The company also commits to measuring and reducing its Scope 3 emissions. The provided data indicates that these SBTi targets were approved using a streamlined validation route for small and medium-sized enterprises (SMEs). The company's emissions data is not cascaded from a parent organization.